Home・Listă Acțiuni・Pharma Mar SA

P
Pharma Mar SA

Deschisă

75.75 -0.59

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

75.35

Maxim

76.85

Indicatori cheie
By Trading Economics
Venit	-58M 1.6M
Vânzări	-48M 43M
P/E Medie Sector	16.753 60.149
EPS	0.088
Marjă de profit	3.725
Angajați	505
EBITDA	-40M 2.7M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+42.95% upside

Dividende
By Acuity
Următoarele câștiguri	29 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-314M 1.3B
Deschiderea anterioară	76.34
Închiderea anterioară	75.75

Pharma Mar SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 iul. 2026, 23:56 UTC

Correlated Moves

Skyworks Solutions Inc shares are higher in after-market trading, supported by positive sentiment in the semiconductor sector and strong earnings from major banks.

14 iul. 2026, 23:56 UTC

JD.Com Inc. shares advanced in after-market trading, supported by strong earnings from major banks and a positive market backdrop. The stock remains above its 20-day moving average.

14 iul. 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF is higher in after-market trading, supported by favorable USD/CNH exchange rate movements and contributions from JD.

14 iul. 2026, 23:56 UTC

Vanguard Total International Bond ETF remains roughly flat in after-market trading. Global equity indices are higher following lower-than-expected U.S. inflation data.

14 iul. 2026, 23:56 UTC

iShares National Muni Bond ETF remains roughly flat in after-market trading. Global equity indices are higher following lower-than-expected U.S. inflation data.

14 iul. 2026, 23:52 UTC

Verisk Analytics Inc shares are lower in after-market hours, with no specific news identified. The decline contrasts with positive sentiment from strong bank earnings.

14 iul. 2026, 23:52 UTC

South Korea's June unemployment rate improves to 2.7%, boosting market confidence amid global economic recovery.

14 iul. 2026, 23:52 UTC

Brazil's Central Bank to Release Key SELIC Rate Insights Amid Global Inflation Concerns on July 20, 2026.

14 iul. 2026, 23:52 UTC

U.S. Industrial Production Data Release on July 17, 2026, Expected to Show Modest Growth Amid Cautious Economic Sentiment and Global Market Volatility.

14 iul. 2026, 23:52 UTC

China's Q2 GDP Growth Rate Expected to Slow to 0.9% Amid Strong Export Surge and Cautious Consumer Sentiment

14 iul. 2026, 23:52 UTC

Japan's upcoming Exports YoY report on July 21, 2026, is generating cautious optimism among investors amid positive regional trends and strong Chinese export data.

14 iul. 2026, 23:52 UTC

Japan's Upcoming Balance of Trade Data on July 21, 2026, Sparks Cautious Investor Sentiment Amidst Persistent Trade Deficits and Global Commodity Price Fluctuations.

14 iul. 2026, 23:51 UTC

U.S. Inflation Drops More Than Expected, Boosting European Equity Futures Amid Geopolitical Tensions

14 iul. 2026, 23:51 UTC

U.S. inflation drops unexpectedly, boosting global equity markets despite mixed results in the U.S. and ongoing geopolitical tensions affecting oil prices.

14 iul. 2026, 23:51 UTC

Asian equity markets rise on strong Chinese trade data, while U.S. stock futures react to softer inflation and mixed earnings amid geopolitical tensions.

14 iul. 2026, 23:51 UTC

U.S. equity markets show mixed results as weaker-than-expected inflation data eases rate hike fears, while geopolitical tensions and strong bank earnings drive volatility.

14 iul. 2026, 23:46 UTC

ETF Constituents

iShares Core MSCI EAFE ETF declines in after-market hours, influenced by top holdings BHP and TM. Performance remains flat since Tuesday's close.

14 iul. 2026, 23:46 UTC

ETF Constituents

iShares Biotechnology ETF declines in after-hours trading, continuing a trend of lower daily closes amid declines from key holdings like EDIT and ADPT.

14 iul. 2026, 23:46 UTC

MercadoLibre Inc shares are higher in after-market hours, supported by strong bank earnings that eased interest rate concerns. No specific news was identified for the stock.

14 iul. 2026, 23:46 UTC

News

PayPal Holdings Inc. shares are lower in after-market trading despite expanding buy now, pay later options in the UK with a new Pay in 30 Days feature.

14 iul. 2026, 23:42 UTC

Japan's Machinery Orders Expected to Decline by -4.2% MoM Amid Geopolitical Tensions and Market Caution

14 iul. 2026, 23:42 UTC

China's Fixed Asset Investment Expected to Contract Further Amid Weak Economic Indicators and Cautious Market Sentiment

14 iul. 2026, 23:42 UTC

China's Industrial Production YoY data for June 2026, expected to rise to 4.6%, set for release on July 15 amid cautious optimism influenced by strong trade figures and geopolitical tensions.

14 iul. 2026, 23:42 UTC

China's Retail Sales Expected to Decline by 0.1% YoY Amid Mixed Economic Signals Ahead of July Release

14 iul. 2026, 23:42 UTC

China's Q2 2026 GDP Growth Rate Expected at 4.5%, Amid Mixed Economic Signals and Global Uncertainties

14 iul. 2026, 23:42 UTC

Bank of Canada's Monetary Policy Report on July 15, 2026, expected to maintain interest rates amid stable inflation and geopolitical tensions.

14 iul. 2026, 23:41 UTC

Event

News

Biogen Inc shares are higher in after-market trading following positive Phase 2 CELIA study results for diranersen, which targets tau in early Alzheimer's disease.

14 iul. 2026, 23:41 UTC

Macro Event

Correlated Moves

Macro News

Crude oil prices have risen, reaching $79 per barrel amid U.S.-Iran tensions. The EUR/USD exchange rate is modestly higher since Monday's close.

14 iul. 2026, 23:41 UTC

Macro News

Macro Event

Correlated Moves

Bitcoin is rising as geopolitical tensions boost oil prices and soft U.S. inflation data eases rate hike fears. Ethereum's gains may further support Bitcoin's momentum.

14 iul. 2026, 23:36 UTC

Autodesk Inc shares advanced after-market, reaching a high of 0.78% since Tuesday's close, despite no specific news driving the movement.

Comparație

Modificare preț

Pharma Mar SA Așteptări

Obiectiv de preț

By TipRanks

42.95% sus

Prognoză pe 12 luni

Medie 110.503 EUR 42.95%

Maxim 121 EUR

Minim 100 EUR

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPharma Mar SA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 2 analiști care au acordat evaluări ale acțiunilor Pharma Mar SA - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Pharma Mar SA

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.